Literature DB >> 21422529

Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience.

Stephen B Wharton1, Carol Brayne, George M Savva, Fiona E Matthews, Gill Forster, Julie Simpson, Gemma Lace, Paul G Ince.   

Abstract

We here describe the study-design major findings from the neuropathological component of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS). MRC CFAS is a population-representative study of aging and health including more than 18000 participants at baseline. More than 500 brain donations were accrued to date and have been subjected to comprehensive pathological assessment. This resource enables a thorough epidemiological description of the neuropathology associated with dementia in the UK. Results to date reveal a high prevalence of mixed Alzheimer and vascular pathology, a significant population who die with dementia but with a more limited pathological burden than is traditionally associated with dementia, and a group who die with a significant pathological burden yet remained cognitively intact until death. This dissociation between pathology and dementia increases with increasing age. Further studies have described the distribution and etiology of neurodegenerative disease in the population, and determined pathological correlates of cognitive impairment and dementia. Brain donation programs linked to epidemiological studies provide an invaluable resource for describing the pathological correlates of dementia in a way that is representative of the population, thereby identifying targets for and assessing the likely effect of therapeutic and preventive interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422529     DOI: 10.3233/JAD-2011-091402

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  30 in total

1.  Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.

Authors:  Catherine C Price; Jared J Tanner; Ilona M Schmalfuss; Babette Brumback; Kenneth M Heilman; David J Libon
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  Vascular disease and dementias: paradigm shifts to drive research in new directions.

Authors:  Mitchel A Kling; John Q Trojanowski; David A Wolk; Virginia M Y Lee; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

3.  Vascular factors in neurodegenerative diseases: a path towards treatment and prevention.

Authors:  Gustavo C Román; François Boller
Journal:  Funct Neurol       Date:  2014 Apr-Jun

Review 4.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

5.  Volume of subclinical embolic infarct correlates to long-term cognitive changes after carotid revascularization.

Authors:  Wei Zhou; Brittanie D Baughman; Salil Soman; Max Wintermark; Laura C Lazzeroni; Elizabeth Hitchner; Jyoti Bhat; Allyson Rosen
Journal:  J Vasc Surg       Date:  2016-12-23       Impact factor: 4.268

Review 6.  Dementia in the oldest old.

Authors:  Zixuan Yang; Melissa J Slavin; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

Review 7.  New horizons: the management of hypertension in people with dementia.

Authors:  Jennifer Kirsty Harrison; Veronika Van Der Wardt; Simon Paul Conroy; David J Stott; Tom Dening; Adam Lee Gordon; Pip Logan; Tomas James Welsh; Jaspal Taggar; Rowan Harwood; John R F Gladman
Journal:  Age Ageing       Date:  2016-11       Impact factor: 10.668

8.  Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.

Authors:  Stephen B Wharton; Julie E Simpson; Carol Brayne; Paul G Ince
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

9.  A latent variable approach to measuring bridging social capital and examining its association to older adults' cognitive health.

Authors:  Siyun Peng; Adam R Roth; Brea L Perry
Journal:  Soc Neurosci       Date:  2021-11-11       Impact factor: 2.083

10.  Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration.

Authors:  Robin Wolz; Adam J Schwarz; Katherine R Gray; Peng Yu; Derek L G Hill
Journal:  Neurology       Date:  2016-08-24       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.